Medical imaging in clinical trials is critical when using imaging data to support your clinical trial. Numerous details should be thoroughly addressed prior to starting the trial including, but not limited to the following:
From the sponsor’s viewpoint, receiving poor quality medical imaging data sets is as bad or worse than receiving no imaging data at all. Regardless of what the clinical trial is studying, patients generally agree to participate with the expectation that all people and companies involved will put forth their best effort to help them, and perhaps advance medicine specific to the disease that is afflicting them. When the primary outcome measure of a study depends on imaging, it is imperative that the imaging be done properly and be of the highest possible quality.
To have a broader discussion regarding the above items or other questions you may have regarding the utilization of imaging to support your clinical trials please contact us 855.463.1633, email@example.com, or medinstitute.com.
Get email about news, services, and events from MED Institute.
We are committed to consistently performing services with high quality, that deliver exceptional results, and add value to the client’s business.
For client surveys sent in the last two quarters, we received ratings of 4.80/5 points (4).